申请人:JANSSEN PHARMACEUTICA NV
公开号:US20130158259A1
公开(公告)日:2013-06-20
2-Aminopyrimidine compounds are described, which are useful as H
4
receptor modulators. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H
4
receptor activity, such as allergy, asthma, autoimmune diseases, and pruritis.
本文描述了2-氨基嘧啶化合物,可用作H4受体调节剂。这些化合物可用于制备药物组合物,并用于治疗由H4受体活性介导的疾病状态、紊乱和条件,例如过敏、哮喘、自身免疫疾病和瘙痒症。